{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T17:05:41Z","timestamp":1753895141827,"version":"3.41.2"},"reference-count":16,"publisher":"Associa\u00e7\u00e3o de Medicina Intensiva Brasileira","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit. Care Sci."],"DOI":"10.62675\/2965-2774.20240017-pt","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T16:45:21Z","timestamp":1729788321000},"source":"Crossref","is-referenced-by-count":0,"title":["Otimiza\u00e7\u00e3o do uso de antibi\u00f3ticos na unidade de terapia intensiva: como fazemos"],"prefix":"10.62675","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1415-3545","authenticated-orcid":false,"given":"Patr\u00edcia","family":"Moniz","sequence":"first","affiliation":[{"name":"Centro Hospitalar de Lisboa Ocidental,  Portugal; Universidade Nova de Lisboa,  Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0692-6202","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Fustiga","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Lisboa Ocidental,  Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3533-7864","authenticated-orcid":false,"given":"Marta Maio","family":"Herculano","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Lisboa Ocidental,  Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7069-7304","authenticated-orcid":false,"given":"Pedro","family":"P\u00f3voa","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Lisboa Ocidental,  Portugal; Universidade Nova de Lisboa,  Portugal"}]}],"member":"49293","published-online":{"date-parts":[[2024]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13613-023-01134-9","article-title":"Antibiotic stewardship in the ICU: time to shift into overdrive","volume":"13","author":"Mokrani D","year":"2023","journal-title":"Ann Intensive Care"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans L","year":"2021","journal-title":"Crit Care Med"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5935\/0103-507X.2022editorial-en","article-title":"Tackling healthcare-associated infections in Brazilian intensive care units: we need more than collaboration","volume":"34","author":"Oliveira RD","year":"2022","journal-title":"Rev Bras Ter Intensiva"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00134-019-05520-5","article-title":"Rationalizing antimicrobial therapy in the ICU: a narrative review","volume":"45","author":"Timsit JF","year":"2019","journal-title":"Intensive Care Med"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: a risk fator for hospital mortality among critically ill patients","volume":"115","author":"Kollef MH","year":"1999","journal-title":"Chest"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1128\/AAC.00627-10","article-title":"Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis","volume":"54","author":"Paul M","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.49353","article-title":"Association of appropriate empirical antimicrobial therapy with in-hospital mortality in patients with bloodstream infections in the US","volume":"6","author":"Ohnuma T","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/cir790","article-title":"Extended-Spectrum Beta-Lactamases\u2013Red Espa\u00f1ola de Investigaci\u00f3n en Patolog\u00eda Infecciosa\/Grupo de Estudio de Infecci\u00f3n Hospitalaria Group. \u03b2-Lactam\/\u03b2-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts","volume":"54","author":"Rodriguez-Ba\u00f1o J","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ijantimicag.2019.02.001","article-title":"Use of non-carbapenem antibiotics to treat severe extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae infections in intensive care unit patients","volume":"53","author":"Luyt CE","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12325-020-01558-w","article-title":"Antimicrobial stewardship in the intensive care unit: the role of biomarkers, pharmacokinetics, and pharmacodynamics","volume":"38","author":"Moniz P","year":"2021","journal-title":"Adv Ther"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3390\/microorganisms9071401","article-title":"Optimizing antimicrobial drug dosing in critically ill patients","volume":"9","author":"P\u00f3voa P","year":"2021","journal-title":"Microorganisms"},{"issue":"6","key":"ref12","first-page":"1127","article-title":"Infection Section of European Society of Intensive Care Medicine (ESICM); Pharmacokinetic\/pharmacodynamic and Critically Ill Patient Study Groups of European Society of Clinical Microbiology and Infectious Diseases (ESCMID); Infectious Diseases Group of International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT); Infections in the ICU and Sepsis Working Group of International Society of Antimicrobial Chemotherapy (ISAC). Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper","volume":"46","author":"Abdul-Aziz MH","year":"2020","journal-title":"Intensive Care Med"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1473-3099(17)30615-1","article-title":"Prolonged versus short-term intravenous infusion of antipseudomonal \u03b2-lactams for patients with sepsis: A systematic review and meta-analysis of Randomised Trials","volume":"18","author":"Vardakas KZ","year":"2018","journal-title":"The Lancet Infectious Diseases"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00134-014-3411-8","article-title":"AZUREA Network Investigators. De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial","volume":"40","author":"Leone M","year":"2014","journal-title":"Intensive Care Med"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/0885066618762747","article-title":"Antibiotic use in the intensive care unit: optimization and de-escalation","volume":"33","author":"Campion M","year":"2018","journal-title":"J Intensive Care Med"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00134-022-06956-y","article-title":"How to use biomarkers of infection or sepsis","volume":"49","author":"P\u00f3voa P","year":"2023","journal-title":"Intensive Care Med"}],"container-title":["Critical Care Science"],"original-title":["Optimization of antibiotic use in the intensive care unit: how we do it"],"link":[{"URL":"https:\/\/criticalcarescience.org\/wp-content\/uploads\/sites\/7\/articles_xml\/2965-2774-ccsci-36-e20240017en\/2965-2774-ccsci-36-e20240017en-pt.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T16:45:27Z","timestamp":1729788327000},"score":1,"resource":{"primary":{"URL":"https:\/\/criticalcarescience.org\/pt-br\/article\/otimizacao-do-uso-de-antibioticos-na-unidade-de-terapia-intensiva-como-fazemos\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":16,"alternative-id":["S2965-27742024000100910"],"URL":"https:\/\/doi.org\/10.62675\/2965-2774.20240017-pt","relation":{"has-translation":[{"id-type":"doi","id":"10.62675\/2965-2774.20240017-en","asserted-by":"subject"}]},"ISSN":["2965-2774"],"issn-type":[{"type":"electronic","value":"2965-2774"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e20240017en"}}